-
Mashup Score: 3
Use of ACE inhibitors and angiotensin receptor blockers was not associated with an increased rate of COVID-19 infection or mortality, according to two meta-analyses reported at the virtual American Heart Association Scientific Sessions. Yujiro Yokoyama, MD, surgeon at St. Luke’s University Health Network’s Easton Hospital, Bethlehem, Pennsylvania, and colleagues conducted two
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2'Definitive Data': Continuing ACE/ARB Tx Safe in COVID-19 - 4 year(s) ago
Randomized trial affirms no harm in mild to moderate coronavirus cases
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 4
Rationale: Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers) is a major concern for clinicians treating coronavirus disease 2019 (COVID-19) in pati…
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Today’s top news highlights: ACE inhibitors in COVID patients, fewer AMI admissions, and more - 4 year(s) ago
Older patients with COVID-19 had a lower risk of developing severe illness if they were taking ACE inhibitors in a new study.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2New observational studies say ACE inhibitors and statins don’t increase COVID-19 risk - AIMed - 4 year(s) ago
The ongoing COVID-19 pandemic not only posed challenges and uncertainties […]
Source: AIMedCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2
HEALTH-CORONAVIRUS/ACE2-MEN (PIX):Men have high levels of enzyme key to COVID-19 infection, study finds
Source: news.trust.orgCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1New angiotensin studies in COVID-19 give more reassurance - 4 year(s) ago
A deluge of new data does not suggest harm with ACE inhibitors and angiotensin blockers in COVID-19 rates or outcomes.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0New angiotensin studies in COVID-19 give more reassurance - 4 year(s) ago
A deluge of new data does not suggest harm with ACE inhibitors and angiotensin blockers in COVID-19 rates or outcomes.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 7
Rationale: Use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) is a major concern for clinicians treating coronavirus disease 2019 (COVID-19) in pati…
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: CardiologistsTweet
Use of #ACE inhibitors or ARBs were found to not be associated with positive rates of #COVID19 or COVID-19 mortality, according to two meta-analyses presented at #AHA20 @AHAMeetings @heartnews #cardiotwitter @mystlukes @EndocrineToday @InfectDisNews https://t.co/W9T4sFLaLJ